Case ReportDigoxin-specific Fab and therapeutic plasma exchange for Digitalis (cas 1339-93-1) intoxication and renal failure
-
Add time:08/30/2019 Source:sciencedirect.com
Treatment of chronic Digitalis (cas 1339-93-1) intoxication includes suspension of drug intake, which may be sufficient in case of mild manifestations, and supportive measures. Severe bradycardia requires the administration of atropine or isoproterenol; placement of a temporary pacemaker may be required in case of absent response to pharmacological therapy. Severe and life-threatening manifestations should be treated with digoxin-specific fragment antigen binding antibodies (Fab). Therapeutic plasma exchange has been suggested, in addition to Fab therapy, to maximize the clearance of Fab-digoxin complexes in patients with renal failure. To date, few case reports have described the use of such a therapeutic approach; currently, extracorporeal methods are not recommended as part of the treatment of digitalis intoxication, and stronger evidence is required to establish their benefit.
We also recommend Trading Suppliers and Manufacturers of Digitalis (cas 1339-93-1). Pls Click Website Link as below: cas 1339-93-1 suppliers
Prev:A green and facile production of catalysts from waste red mud for the one-pot synthesis of glycerol carbonate from glycerol
Next:Effect of Digitalis (cas 1339-93-1) level on readmission and mortality rate among heart failure reduced ejection fraction patients) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Novel perspectives on two Digitalis (cas 1339-93-1) species: Phenolic profile, bioactivity, enzyme inhibition, and toxicological evaluation09/07/2019
- Review ArticleDigitalis (cas 1339-93-1), A Targeted Therapy for Cancer?09/06/2019
- Three seasonal comprehensive evaluation process of Digitalis (cas 1339-93-1) trojana Ivan’s phenolics09/05/2019
- Arrhythmia GraphicsDigitalis (cas 1339-93-1) toxicity: ECG vignette09/04/2019
- New knowledge about old drugs; a cardenolide type glycoside with cytotoxic effect and unusual secondary metabolites from Digitalis (cas 1339-93-1) grandiflora Miller09/03/2019
- Cytotoxic phenylethanoid glycosides from Digitalis (cas 1339-93-1) davisiana Heywood: Evaluation of structure activity relationships and chemotaxonomical significance of isolated compounds09/02/2019
- Alternans during fascicular ventricular tachycardia due to Digitalis (cas 1339-93-1) toxicity09/01/2019
- Effect of Digitalis (cas 1339-93-1) level on readmission and mortality rate among heart failure reduced ejection fraction patients08/31/2019